369 related articles for article (PubMed ID: 12489321)
1. [Osteoporosis in the aged male].
Szulc P; Delmas PD
Presse Med; 2002 Nov; 31(37 Pt 1):1760-9. PubMed ID: 12489321
[TBL] [Abstract][Full Text] [Related]
2. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
[TBL] [Abstract][Full Text] [Related]
3. Osteoporosis in men.
Seeman E
Baillieres Clin Rheumatol; 1997 Aug; 11(3):613-29. PubMed ID: 9367040
[TBL] [Abstract][Full Text] [Related]
4. Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden.
Mellström D; Johnell O; Ljunggren O; Eriksson AL; Lorentzon M; Mallmin H; Holmberg A; Redlund-Johnell I; Orwoll E; Ohlsson C
J Bone Miner Res; 2006 Apr; 21(4):529-35. PubMed ID: 16598372
[TBL] [Abstract][Full Text] [Related]
5. Preventing osteoporotic fractures in older people.
McCloskey E
Practitioner; 2011 Jan; 255(1736):19-22, 2-3. PubMed ID: 21370710
[TBL] [Abstract][Full Text] [Related]
6. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F
J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
[TBL] [Abstract][Full Text] [Related]
7. Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: a randomized controlled trial.
Sato Y; Iwamoto J; Kanoko T; Satoh K
Mov Disord; 2006 Jul; 21(7):924-9. PubMed ID: 16538619
[TBL] [Abstract][Full Text] [Related]
8. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
[TBL] [Abstract][Full Text] [Related]
9. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
[TBL] [Abstract][Full Text] [Related]
10. Inadequate dietary calcium intake in elderly patients with hip fractures.
Lee YH; Lim YW; Ling PS; Tan YY; Cheong M; Lam KS
Singapore Med J; 2007 Dec; 48(12):1117-21. PubMed ID: 18043839
[TBL] [Abstract][Full Text] [Related]
11. Present and future of osteoporosis therapy.
Seeman E; Tsalamandris C; Bass S; Pearce G
Bone; 1995 Aug; 17(2 Suppl):23S-29S. PubMed ID: 8579894
[TBL] [Abstract][Full Text] [Related]
12. Antiresorption therapy and reduction in fracture susceptibility in the osteoporotic elderly patient: open study.
Muscoso E; Puglisi N; Mamazza C; Lo Giudice F; Testai M; Abbate S; Santangelo A; Panebianco P; Maugeri D
Eur Rev Med Pharmacol Sci; 2004; 8(2):97-102. PubMed ID: 15267123
[TBL] [Abstract][Full Text] [Related]
13. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
Seibel MJ; Naganathan V; Barton I; Grauer A
J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
[TBL] [Abstract][Full Text] [Related]
14. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
Ettinger MP
Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
[TBL] [Abstract][Full Text] [Related]
15. An investigation of the predictors of bone mineral density and response to therapy with alendronate in osteoporotic men.
Drake WM; Kendler DL; Rosen CJ; Orwoll ES
J Clin Endocrinol Metab; 2003 Dec; 88(12):5759-65. PubMed ID: 14671165
[TBL] [Abstract][Full Text] [Related]
16. Osteoporosis Clinical Guideline. South African Medical Association--Osteoporosis Working Group.
Hough S
S Afr Med J; 2000 Sep; 90(9 Pt 2):907-44. PubMed ID: 11081144
[TBL] [Abstract][Full Text] [Related]
17. Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study.
Shane E; Rodino MA; McMahon DJ; Addesso V; Staron RB; Seibel MJ; Mancini D; Michler RE; Lo SH
J Heart Lung Transplant; 1998 Nov; 17(11):1089-96. PubMed ID: 9855448
[TBL] [Abstract][Full Text] [Related]
18. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
[TBL] [Abstract][Full Text] [Related]
19. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
Brodowska A
Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
[TBL] [Abstract][Full Text] [Related]
20. Preventing osteoporotic fractures with antiresorptive therapy: implications of microarchitectural changes.
Boonen S; Haentjens P; Vandenput L; Vanderschueren D
J Intern Med; 2004 Jan; 255(1):1-12. PubMed ID: 14687233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
